Prenatal dexamethasone treatment of fetuses at risk for congenital adrenal hyperplasia: Benefits and concerns

Seminars in Neonatology

Volumn 6, Issue 4, 2001, Pages 357-362

  Ritzén, E Martin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Congenital adrenal hyperplasia; Dexamethasone; Prenatal treatment; Virilization

Indexed keywords

DEXAMETHASONE;

AUTOSOMAL RECESSIVE DISORDER; CHORION VILLUS; CONGENITAL ADRENAL HYPERPLASIA; DNA DETERMINATION; DRUG INDICATION; DRUG MEGADOSE; FEMALE; FETUS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; NONHUMAN; PRENATAL DRUG EXPOSURE; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; VIRILIZATION;

EID: 0035740132     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2001.0071     Document Type: Article

References (25)

1. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
2. Mutational spectrum of the steriod 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation
3. How can molecular biology contribute to the management of congenital adrenal hyperplasia?
4. Attempted prevention of abnormal genital masculinization in congenital adrenal hyperplasia (CAH) by adrenocortical suppression in utero
5. Prenatal therapy in congenital adrenal hyperplasia: Attempted prevention of abnormal external genital masculinization by pharmacologic suppression of the fetal adrenal gland in utero
6. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency
7. Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Up-date 88 of the French multicentric study
8. First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-Hydroxylase deficiency)
9. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
10. Prenatal diagnosis/treatment in families at risk for infants with steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia)
11. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency
12. Prenatal diagnosis, treatment, and outcome in infants with congenital adrenal hyperplasia
13. Prenatal treatment of congenital adrenal hyperplasia
14. Congenital adrenal hyperplasia: Update on prenatal diagnosis and treatment
15. Glucocorticoid exposure in utero; a new model for adult hypertension
16. How safe is long-term prenatal glucocorticoid treatment?
17. Prenatal treatment of congenital adrenal hyperplasia: A promising experimental therapy of unproven safety
18. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia
19. Antenatal treatment of a mother bearing a foetus with congenital adrenal hyperplasia
20. Prenatal treatment of congenital adrenal hyperplasia: A commentary
21. Technical report: Congenital adrenal hyperplasia
22. Prenatal treatment of congenital adrenal hyperplasia: Author differs with technical report
23. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring
24. Neurotoxicity of glucocorticoids in the primate brain
25. Effects of early prenatal dexamethasone on the cognitive and behavioural development of young children: Results of a pilot study